8 transcripts
PRPO
Earnings call transcript
NASDAQ
2022 Q3
14 Nov 22
responsibility for the company's situation and hold myself accountable. Furthermore, our management team has also held accountable, and we've all been
PRPO
Earnings call transcript
NASDAQ
2021 Q1
21 May 21
, and it was certainly nice to see the strong market response. I believe at that day, we were among the top five most highly rated companies. And for a small company
PRPO
Earnings call transcript
NASDAQ
2020 Q4
1 Apr 21
will always be our core business. Pathology business starts with our sales team responsible for the growth we describe on the top
PRPO
Earnings call transcript
NASDAQ
2020 Q3
19 Nov 20
away from full deployment of the vaccine to the broad population. Secondly, the vaccine is intended to generate a response in the body
PRPO
Earnings call transcript
NASDAQ
2020 Q2
17 Aug 20
and a diagnostic company, we have a responsibility to contribute to the battle given the tremendous testing deficiency in the U.S. In summary, I feel we’ve
rce
Earnings call transcript
NASDAQ
2019 Q3
13 Nov 19
to overcome any bumps we face and we are committed to continuing down this path of growth.
Second, is our commitment to fiscal responsibility
v4
Earnings call transcript
NASDAQ
2018 Q3
19 Nov 18
, while my team and I strongly believe in the pipeline and growth trajectory of the company, we cannot rely solely on that. Any responsible manager
v4u
Earnings call transcript
NASDAQ
2018 Q2
23 Aug 18
the investor to maximize shareholder value in a responsible manner. This brings me to the second point I like to address the share price and our NASDAQ listing
- Prev
- 1
- Next